A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models
ConclusionsOverall, the CPT-11 liposome may be developed as a new clinical alternative for the cancer patients.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Drugs & Pharmacology | Gastric (Stomach) Cancer | Gastroenterology | Pancreas | Pancreatic Cancer | Study | Toxicology